{
    "paper_id": "cc11bbcca30ca2002b32b857b034a02f5a330903",
    "metadata": {
        "title": "Journal Pre-proofs Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories",
        "authors": [
            {
                "first": "Takayuki",
                "middle": [],
                "last": "Ishige",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Shota",
                "middle": [],
                "last": "Murata",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Toshibumi",
                "middle": [],
                "last": "Taniguchi",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Akiko",
                "middle": [],
                "last": "Miyabe",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Kouichi",
                "middle": [],
                "last": "Kitamura",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Kenji",
                "middle": [],
                "last": "Kawasaki",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Motoi",
                "middle": [],
                "last": "Nishimura",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hidetoshi",
                "middle": [],
                "last": "Igari",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Kazuyuki",
                "middle": [],
                "last": "Matsushita",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "The global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute 4 respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared by the World Health 5 Organization (WHO) in March 2020 [1] . Currently, clinical diagnosis of COVID-19 is 6 confirmed by detecting SARS-CoV-2 RNA by molecular diagnostic laboratories using the real-7 time reverse transcription-polymerase chain reaction (rRT-PCR) [2] [3] [4] [5] . 8 We analyzed two regions of the N genes used to detect SARS-CoV-2 RNA by simplex one-9 step rRT-PCR using the previously described primer/probe sets N_Sarbeco and NIID_2019- 29 Three genes were designed: a Sarbecovirus-specific E gene (E_Sarbeco, target), a SARS-CoV- 37 We used a synthetic RNA control with the N gene (CTRL-N) with a previously described ",
            "cite_spans": [
                {
                    "start": 200,
                    "end": 203,
                    "text": "[1]",
                    "ref_id": null
                },
                {
                    "start": 408,
                    "end": 411,
                    "text": "[2]",
                    "ref_id": null
                },
                {
                    "start": 412,
                    "end": 415,
                    "text": "[3]",
                    "ref_id": null
                },
                {
                    "start": 416,
                    "end": 419,
                    "text": "[4]",
                    "ref_id": null
                },
                {
                    "start": 420,
                    "end": 423,
                    "text": "[5]",
                    "ref_id": null
                },
                {
                    "start": 426,
                    "end": 427,
                    "text": "8",
                    "ref_id": null
                },
                {
                    "start": 601,
                    "end": 603,
                    "text": "29",
                    "ref_id": null
                },
                {
                    "start": 695,
                    "end": 697,
                    "text": "37",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "The LOD was analyzed using serially diluted synthetic control RNA samples (2500, 250, 25, 87 5 and 2.5 copies/reaction). The C q values and detection rates are shown in Table 1 93 We compared the three primer/probe sets NIID-N, N_Sarbeco and E_Sarbeco. The E_Sarbeco 102 We compared the C q values of simplex and multiplex rRT-PCR using six SARS-CoV-2 RNA-103 positive samples (Figure 1 ) and observed good correlation between the targets. However, the 104 C q values of N_Sarbeco showed an average delay of 6.4 cycles (a minimum of 5.5 to a 105 maximum of 7.5). Similar results for C q values were obtained using simplex NIID-N, multiplex 106 NIID-N and multiplex E_Sarbeco. These results indicate that the sensitivity of NIID-N was not 107 decreased by multiplexing, and E_Sarbeco and NIID-N had equal sensitivity. We also tested 108 another nucleic acid extraction kit (High Pure Viral RNA Kit, Roche). Although the C q values 109 were slightly higher than those obtained using a Maxwell RSC Viral Total Nucleic Acid ",
            "cite_spans": [
                {
                    "start": 177,
                    "end": 179,
                    "text": "93",
                    "ref_id": null
                },
                {
                    "start": 267,
                    "end": 270,
                    "text": "102",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 169,
                    "end": 176,
                    "text": "Table 1",
                    "ref_id": null
                },
                {
                    "start": 377,
                    "end": 386,
                    "text": "(Figure 1",
                    "ref_id": "FIGREF5"
                }
            ],
            "section": "86"
        },
        {
            "text": "The SARS-CoV-2 test results obtained using the novel multiplex rRT-PCR are shown in Figure   115 2. Twenty-four clinical specimens were analyzed. Four positive and twenty negative results We developed a multiplex rRT-PCR methodology for the molecular diagnosis of COVID-19.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 84,
                    "end": 96,
                    "text": "Figure   115",
                    "ref_id": "FIGREF5"
                }
            ],
            "section": "Highly sensitive detection of the SARS-CoV-2 E and N genes 114"
        },
        {
            "text": "The sensitivity of RT-PCR is affected by various factors, such as the nucleic acid extraction 5 133 method, the one-step RT-PCR reagent, and the primer/probe sets. Optimization experiments 134 are required prior to using this methodology in clinical settings. 135 Current results indicate that: 1) the NIID-N set is slightly more sensitive than E_Sarbeco; 2) 136 NIID-N and E_Sarbeco are a good combination for detecting two regions of the SARS-CoV-2 137 genome with high sensitivity; and 3) the human ABL1 gene is useful as an IC for checking the 138 qualities of the specimen, nucleic acid extraction step, and RT-PCR amplification. Therefore, 139 we demonstrated that this highly sensitive multiplex rRT-PCR methodology can detect SARS-140 CoV-2.",
            "cite_spans": [
                {
                    "start": 260,
                    "end": 263,
                    "text": "135",
                    "ref_id": null
                },
                {
                    "start": 646,
                    "end": 649,
                    "text": "139",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "132"
        },
        {
            "text": "The human ABL1 gene is recommended as an IC gene for the molecular diagnosis and 142 monitoring for minimal residual disease detection [7] . Many molecular diagnostic laboratories 143 use this primer/probe set. We did not use the ACTB and GAPDH genes, which are also 144 frequently used as ICs, because they are more abundantly expressed than the ABL1 gene [9].",
            "cite_spans": [
                {
                    "start": 135,
                    "end": 138,
                    "text": "[7]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "141"
        },
        {
            "text": "In multiplex PCR, the amplification of highly abundant targets may prevent the amplification 146 of less abundant targets, possibly lowering the sensitivity of target detection.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "145"
        },
        {
            "text": "The background of E_Sarbeco was slightly increased in later cycles. We judged these signals 148 as negative results because: 1) reproducibility was poor (negative upon retesting with the 149 same assay), 2) NIID-N did not show positive results, although it has equal sensitivity to ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "147"
        },
        {
            "text": "Since these results may lead to false-positive results, care must be taken when judging weak 153 positive signals.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "152"
        },
        {
            "text": "The SARS-CoV-2 pandemic has resulted in a shortage of reagents related to the molecular 155 diagnosis. The proposed multiplex rRT-PCR methodology will enable highly sensitive 156 detection of SARS-CoV-2 RNA, reducing reagent use and cost, and time required by clinical",
            "cite_spans": [],
            "ref_spans": [],
            "section": "154"
        }
    ],
    "bib_entries": {
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Detection of 2019 novel coronavirus 173 (2019-nCoV) by real-time RT-PCR",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Goossens",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P G"
                    ],
                    "last": "Reusken",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Koopmans",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Drosten",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Euro. Surveill",
            "volume": "25",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan",
            "authors": [],
            "year": 2020,
            "venue": "Jpn. J. Infect. Dis",
            "volume": "177",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Rapid establishment of laboratory diagnostics for the novel coronavirus 180 SARS-CoV-2 in Bavaria",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ackermann",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Sing",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Euro. Surveill",
            "volume": "25",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Molecular Diagnosis of a Novel Coronavirus 183 (2019-nCoV) Causing an Outbreak of Pneumonia",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Wan",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "L M"
                    ],
                    "last": "Peiris",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Poon",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin. Chem",
            "volume": "66",
            "issn": "",
            "pages": "549--555",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Coronavirus disease (COVID-19) technical guidance: 185 Laboratory testing for 2019-nCoV in humans",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Evaluation of candidate control genes for diagnosis and residual disease 191 detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase 192 chain reaction (RQ-PCR) -a Europe against cancer program",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hokland",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Gabert",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Leukemia",
            "volume": "17",
            "issn": "",
            "pages": "2474--2486",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Evaluation of a quantitative RT-PCR 194 assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput 195 system",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pfefferle",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Reucher",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "N\u00f6rz",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "L\u00fctgehetmann",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Euro. Surveill",
            "volume": "25",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Molecular monitoring of chronic 197 myelogenous leukemia: identification of the most suitable internal control gene for real-time 198 quantification of BCR-ABL transcripts",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "L"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Cesarman",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "K"
                    ],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Csernus",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J. Mol. Diagn",
            "volume": "8",
            "issn": "",
            "pages": "231--239",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Six samples were analyzed by simplex rRT-PCR",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Simplex rRT-PCR with 205 NIID-N was used as a reference (y axis). The dashed line indicates the y=x line",
            "authors": [
                {
                    "first": ")",
                    "middle": [],
                    "last": "N_Sarbeco",
                    "suffix": ""
                },
                {
                    "first": "E_Sarbeco",
                    "middle": [],
                    "last": "Multiplex Rrt-Pcr (niid-N",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Results of SARS-CoV-2 detection using the novel multiplex rRT-PCR method. CTRL-C and 209",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "included 400 copies/reaction of SARS-CoV-2 RNA and 25 copies/reaction of 210 synthetic RNA containing the N region, respectively (red solid lines). The dotted (green) and 211 dashed (blue) lines indicate negative and positive results for the clinical specimens",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ctrl-N",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "10 nCOV_N (NIID-N) [3]. However, this method requires improvement as a molecular diagnostic 11 test used by clinical laboratories. The WHO recommended the detection of at least two different 12 targets on the COVID-19 virus genome. For example, Corman et al. recommended the E gene 13 assay as the first-line screening tool, followed by confirmatory testing with the RdRp gene 14 assay [2, 6]. However, our experiments and previous reports show that the N_Sarbeco set is 15 less sensitive than the NIID-N set [2,3]. In cases where NIID-N is weakly positive and 16 N_Sarbeco is negative, we have found it difficult to judge whether results are true positives or 17 false positives, indicating the need for another assay with sensitivity equal to the NIID-N set 18 to detect two regions of the COVID-19 genome with high sensitivity. In addition, an internal 19 control assay is required for evaluating the qualities of the specimen, nucleic acid extraction 20 step, and RT-PCR amplification [6]. 21 Here, we developed a multiplex rRT-PCR methodology for the simultaneous detection of two 22 regions of the SARS-CoV-2 genome (E and N genes), and of the human ABL1 gene. The 23 qualities of the clinical specimen and of the RT-PCR assay can be evaluated by using the 24 human ABL1 gene as an internal control (IC) [7].",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "N gene (NIID-N, target), and a human ABL1 gene (IC). The primers and probes were 31 referred from previous research [2, 3, 7] and the sequences are described inTable 1. Primers 32 and probes were purchased from Integrated DNA Technologies (Coralville, IA, USA). The 4\u00d7 33 primer/probes mixes were prepared at the following concentrations: E_Sarbeco and NIID-N, 2 34 0.8 \u03bcM of primer and 0.4 \u03bcM of probe; ABL1 gene, 0.4 \u03bcM of primer and 0.2 \u03bcM of probe. 35 36",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "38 sequence [2], gifted by the National Institute of Infectious Disease (NIID; Tokyo, Japan). We 39 prepared another control sample (CTRL-C) using SARS-CoV-2 test positive total nucleic acid 40 solution extracted from a clinical specimen and total RNA solution extracted from the K562 41 cell line.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Sample preparation and viral RNA extraction 44 Thirty sputum samples from patients who underwent routine clinical SARS-CoV-2 tests 45 (simplex RT-PCR with NIID-N) were prepared using a DTT solution containing 20 mM DTT 46 in Dulbecco's phosphate-buffered saline (Sigma-Aldrich, St. Louis, MO, USA). The sputum 47 samples were mixed well with the DTT solution at a volume ratio of 2:1. After incubation for 48 10 min at room temperature, the samples were centrifuged at 1500 \u00d7 g for 5 min. Nucleic acids 49 were extracted from 200 \u03bcL of supernatant and viral RNA was extracted using a Maxwell RSC 50 Viral Total Nucleic Acid Purification Kit (Promega, Madison, WI, USA) using a Maxwell RSC 51 Instrument (Promega). Total nucleic acid was eluted in 50 \u03bcL of nuclease-free water.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Cobas z 480 instrument (Roche Diagnostics, Mannheim, Germany) was used for rRT-PCR.55    All reagents were brought to room temperature prior to preparing the master mix because56 preparing the mix on ice can result in occasional non-specific signal increases. Each 10-\u03bcL 57 reaction mixture contained 2.5 \u03bcL of 4\u00d7 TaqPath 1-Step Multiplex Master Mix (No ROX; 58 Thermo Fisher Scientific, Waltham, MA, USA), 2.5 \u03bcL of 4\u00d7 primer/probes mix, and 2.5 \u03bcL 59 of extracted total nucleic acid. The final concentrations of primers and probes were 0.2 \u03bcM 60 (target primers), 0.1 \u03bcM (target probes), 0.1 \u03bcM (IC primer), and 0.05 \u03bcM (IC probe). The 61 cycling program was as follows: uracil DNA glycosylase incubation at 37\u00b0C for 2 min; reverse 62 transcription at 55\u00b0C for 10 min; polymerase activation at 95\u00b0C for 2 min; and 45 cycles of 63 PCR at 95\u00b0C for 3 sec and 60\u00b0C for 30 sec (signal acquisition). The filter combinations were 64 465-510 (FAM), 540-580 (HEX), and 610-670 (Cy5). The melt factor, quant factor, and max 65 integration times were 1, 10, and 2 sec, respectively. No color compensation experiment was 66 performed because Cobas z 480 instruments contain calibrated filters. The C q One-step RT-PCR reagents and probe chemistries 72 Simplex rRT-PCR with NIID-N was performed using a synthetic RNA control with 2500 73 copies/reaction as the rRT-PCR template. Each experiment was performed in duplicate. First, 74 we compared the three one-step RT-PCR reagents TaqPath 1-Step Multiplex Master Mix, 75 QuantiTect Probe RT-PCR Kit (Qiagen, Hilden, Germany), and LightCycler Multiplex RNA 76 Virus Master (Roche); the average C q values and standard deviations (SD) were 24.5 (0.11), 77 26.9 (0.064), and 26.8 (0.11), respectively. Second, we compared two probe chemistries: 78 FAM/TAMRA (a single-quenching probe) and FAM/ZEN/IBFQ (a double-quenching probe). 79 The average difference between the maximum and minimum fluorescence intensities and SD 80 were FAM/TAMRA 9.1 (0.21) and FAM/ZEN/IBFQ 10.1 (0.30). The signal-to-noise ratio was 81 11% higher using FAM/ZEN/IBFQ and thus TaqPath 1-Step Multiplex Master Mix and the 82 double-quenching probes were selected because of their low C q value and improved signal-to-83 noise ratio, respectively.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "the same SARS-CoV-2 positive samples were 26.2 (NIID-N), 29.9 (N_Sarbeco), and 96 25.5 (E_Sarbeco). The NIID-N and E_Sarbeco sets were selected for multiplexing because of 97 their sensitivities. In addition, the human ABL1 gene was included as an IC in the novel 98 multiplex rRT-PCR assay to evaluate the qualities of the clinical specimens (e.g., sputum and 99 nasopharyngeal swabs), nucleic acid extraction, and RT-PCR.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "116 were confirmed by simplex rRT-PCR. The four positive samples were NIID-N-positive and 117 the N_Sarbeco-negative results were confirmed by simplex rRT-PCR. Although these samples 118 had low copies (<25 copies/reaction as determined by NIID-N), a concordant result was 119 obtained using the novel multiplex rRT-PCR method. In addition, in one of the four samples, 120 the novel multiplex rRT-PCR method could simultaneously detect two regions of SARS-CoV-121 2 RNA (N and E genes) and the human ABL1 gene. Four target positive samples (NIID-122 N/E_Sarbeco: positive/positive, N=1; positive/negative, N=3) were obtained from the same 123 patient. The SARS-CoV-2 RNA of these samples calculated by NIID-N were 15, 16 (also 124 determined by E_Sarbeco, 19 copies/reaction), 5, and 2 copies/reaction. Twenty samples 125 provided negative results for SARS-CoV-2. The C q values for the ABL1 gene in these samples 126 were less than 35 cycles (minimum 24.6, average 28.6, maximum 32.3), and the assay quality 127 was validated.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": "the maximum signal intensities were significantly lower than the positive 151 signals with low-copy samples, and 4) similar observations were reported previously [2, 4].",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": ". The slope, intercept, and R 2 were \u22123.23, 35.6, and 0.997, respectively. The calculated PCR efficiency 89 [10^(-1/slope)] was 2.04. The detection rate was 100% up to 25 copies/reaction. The calculated LOD with 95% detection probability was 21 copies/reaction.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}